Showing results (1621-1630 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|November 26, 2025
Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9)Alexandru Eniu, Runcie C W Chidebe, Peter Vuylsteke, et al.
Breast (Edinburgh, Scotland)|November 26, 2025
Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3)Karen Gelmon, Cynthia Villarreal-Garza, Dawn Aubel, et al.
Breast (Edinburgh, Scotland)|January 18, 2026
The efficacy of intra-operative injection of [99mTc] labelled colloidal nanoparticles for sentinel lymph nodes identification in breast cancerOr Barkai, Itamar Ashkenazi, Aviad Hoffman
Breast (Edinburgh, Scotland)|January 21, 2026
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort studyJustyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
Breast (Edinburgh, Scotland)|February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysisLuca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.
Breast (Edinburgh, Scotland)|October 29, 2025
Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patternsXi Cai, Yuying Chen, Qianqian Li, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Effectiveness of hybrid digital breast tomosynthesis/digital mammography in women presenting for routine screening at Maroondah BreastScreen, Australia: Interim analysisM Luke Marinovich, Darren Lockie, Michelle Giles, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trialHangcheng Xu, Yan Wang, Qiang Sa, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort studyXu Zhang, Zheng Wang, Yiwei Tong, et al.
Pageof 366